July 24, 2020 / 6:15 AM / 11 days ago

AstraZeneca's lung disease treatment gets FDA nod

July 24 (Reuters) - The U.S. Food and Drug Administration approved AstraZeneca’s drug to treat patients with a form of lung disease, the drugmaker said on Friday.

The drug Breztri Aerosphere is being approved as a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), the third leading cause of death globally, the British drugmaker said. (Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Shounak Dasgupta)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below